Skip to main navigation Skip to search Skip to main content

Intravenous carbon dioxide as an echocardiographic contrast agent

  • Erasmus MC

Research output: Contribution to a Journal (Peer & Non Peer)Articlepeer-review

39 Citations (Scopus)

Abstract

Intravenous carbon dioxide (CO2) was employed to cause echocardiographic contrast in 40 patients. One to 3 cc of medically pure CO2 were agitated with 5 to 8 cc of 5% dextrose in water and rapidly injected into an upper extremity vein. Contrast was obtained in all patients. In 33 patients contrast density from 5% dextrose was compared with that from 5% dextrose‐CO2 injections. Six of these patients had no contrast on the initial 5% dextrose injection and definite contrast with the subsequent injection containing CO2. Of the 33, 12 patients had initial contrast with 5% dextrose injections and greater contrast density when CO2 was added; 15 showed no definite difference; and none had less contrast with intravenous CO2‐5% dextrose than with 5% dextrose alone. Intravenous CO2‐5% dextrose is a useful method of increasing contrast in those patients who fail to demonstrate echocardiographic contrast when routine techniques are employed. It is also safe, provided precautions emphasized in this paper are observed.

Original languageEnglish
Pages (from-to)127-131
Number of pages5
JournalJournal of Clinical Ultrasound
Volume9
Issue number3
DOIs
Publication statusPublished - Mar 1981
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 13 - Climate Action
    SDG 13 Climate Action

Keywords

  • Carbon dioxide
  • Echocardiography
  • Ultrasound contrast

Fingerprint

Dive into the research topics of 'Intravenous carbon dioxide as an echocardiographic contrast agent'. Together they form a unique fingerprint.

Cite this